News & Updates

Treatment with repeated low-level red-light (RLRL) therapy with 100-percent power results in significant reduction in myopia progression over 6 months in myopic children when compared to a sham device with 10-percent original power, a China study has shown. In addition, the RLRL therapy is well tolerated and does not lead to serious adverse effects (AEs)

The term ‘papilledema’ is often used inappropriately among case reports in ophthalmology, reveals a recent study. Such misuse, if not corrected, can result in improper care delivery to patients with optic disc edema (ODE), which may then lead to permanent vision loss.

Use of proprotein convertase subtilisin-like/kexin type 9 (PCSK9) inhibitors appears to increase the risk of ocular disorders, as shown in a study.

A trio of engineers has developed a smart cane that provides navigation assistance with warning vibrations and spoken directions, enhancing the independence of people with blindness or visual impairments by helping them find a seat in a public space or the right products in a grocery store, among others.

A recent study reports an overall risk of 8.6 percent for hydroxychloroquine (HCQ) retinopathy after 15 years in a large cohort with active surveillance retinopathy screening. Notably, most of these cases are mild, and a higher HCQ dose appears to result in progressively greater risk for incident retinopathy.

The number of optical coherence tomography (OCT) scans must be increased relative to current clinical practice to get a more accurate diagnosis of retinal nerve fibre layer (RNFL) worsening, according to a recent study.